IACT Health
Centricity Research (operating as IACT Health) is a private, North American multi-site clinical research network that conducts trials across 35+ therapeutic areas for pharmaceutical sponsors and CROs, recruiting patients via its website, physician referrals, and free health screenings.
- Company typePrivate
- Founded2005
- HeadquartersColumbus, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What IACT Health does
IACT Health, which operates under the brand and legal name Centricity Research, is a private clinical research site network founded in 2005 that conducts clinical trials on behalf of pharmaceutical sponsors and contract research organizations (CROs) across the United States and Canada. The company operates physical research sites under bilateral headquarters in Columbus, Georgia (USA) and Toronto, Ontario (Canada), and covers 35+ therapeutic areas including oncology, cardiology, pulmonology, and endocrinology. According to its own disclosures, the network has completed 3,500+ clinical studies, facilitated 100+ FDA and Health Canada drug approvals, and served 25,000+ patients cumulatively.
The business is structured as a professional-services clinical trial execution platform with two-sided demand. On the sponsor side, the company sells site capacity, patient enrollment, and study execution services to pharmaceutical companies and CROs through a dedicated business development function. On the patient side, it recruits participants through its own website (with paid study enrollment), a network of referring physicians, and free health-screening programs (FibroScan for liver health, peanut allergy screening, memory tests). Jeff Kingsley serves as CEO and Chair of the Board. The website-centricity brand is supported by separate US and Canadian social media accounts across Instagram, Facebook, LinkedIn, and TikTok, and contact paths include a US business line and a Canadian business line.
In October 2024 the company acquired North Carolina-based Lucas Research, extending its US southeastern footprint and adding therapeutic-area capabilities, consistent with an active site-consolidation strategy. Revenue, funding, and ownership details are not publicly disclosed; Lucas Research is listed as a wholly owned subsidiary with its brand retained.
IACT Health firmographics
Firmographics- Name
- IACT Health
- Legal name
- Centricity Research
- Website
- https://iacthealth.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Centricity Research (operating as IACT Health) is a private, North American multi-site clinical research network that conducts trials across 35+ therapeutic areas for pharmaceutical sponsors and CROs, recruiting patients via its website, physician referrals, and free health screenings.
- Ownership category
- akta.pro rank
IACT Health industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industries
- Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)
Keywords
Where IACT Health is headquartered
LocationHeadquarters
- HQ city
- Columbus
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
IACT Health business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D, Others
Revenue model
- Clinical Trial Site Services: Revenue generated from conducting clinical trials for pharmaceutical sponsors and CROs. The company operates research sites across the US and Canada where clinical trials are conducted, earning fees for patient enrollment, study execution, and data collection services.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels4 records
IACT Health product offering
Product offeringCore offering
IACT Health (operating as Centricity Research) operates one of the largest clinical research site networks in North America, with sites across the US and Canada. The company conducts clinical trials for pharmaceutical sponsors and Contract Research Organizations (CROs) across 35+ therapeutic areas including oncology, cardiology, pulmonology, and endocrinology, earning fees for patient enrollment, study execution, and data collection. Patients can also apply directly through the company's website to join paid clinical research studies, with additional free health screening services such as FibroScan, peanut allergy screening, and memory tests.
Product overview
The company operates as a unified clinical research network offering end-to-end clinical trial services. Their portfolio encompasses patient recruitment and enrollment across 35+ therapeutic areas, free health screening services (including FibroScan for liver health, peanut allergy screening, and memory tests), and business development services for pharmaceutical sponsors and CROs. The network has conducted 3,500+ studies, facilitated 100+ FDA and Health Canada drug approvals, and serves 25,000+ patients across sites in the US and Canada.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Trial Site Services for Sponsors and CROs End-to-end clinical trial execution services for pharmaceutical sponsors and Contract Research Organizations, including patient recruitment and enrollment, study protocol execution, and data collection across 35+ therapeutic areas at research sites in the US and Canada. The service is intended for drug development companies seeking to bring new medicines to market by leveraging an established multi-site network.
- Paid Clinical Research Study Enrollment Self-serve program through which individual patients and healthy volunteers apply via the company website to join paid clinical research studies across multiple therapeutic areas. Participants may receive compensation for their participation and access to free health screenings. The service feeds the sponsor pipeline and supports recruitment timelines.
- Free Health Screening Services Free health screening services offered to community members, including FibroScan liver assessments, peanut allergy screenings, and memory tests. These screenings serve as a community engagement and patient recruitment touchpoint for clinical research participation.
Quantifiable outcome
- 100+ FDA & Health Canada drug approvals facilitated
- +1 more outcomes
Companies that use IACT Health
Customer profileSegments3 records
Ideal customer profiles3 records
IACT Health technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
IACT Health partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Lucas ResearchcoreCentricity Research acquired North Carolina-based Lucas Research in October 2024, expanding its clinical research footprint across North America and adding to its therapeutic area capabilities. This acquisition strengthens the company's presence in the southeastern United States and broadens the range of conditions studied through their network.
Scale indicators5 records
Recent moves4 records
Expansion highlights6 records
IACT Health competitors and assessment
Company assessmentBroad incumbents
- Medpace: Medpace is a global mid-sized CRO focused on full-service clinical development across multiple therapeutic areas. It competes with Centricity at the sponsor level for trial execution contracts and indirectly for the same patient populations.
- ICON plc: ICON plc is one of the largest global CROs after acquiring PRA Health Sciences, offering end-to-end clinical development services. It is a broader incumbent competing for large multi-region trials that may otherwise engage networks like Centricity.
- IQVIA: IQVIA is the largest global CRO with deep clinical trial site operations and real-world data capabilities. It is a broader incumbent that competes with Centricity for large sponsor programs, though it serves a much wider portfolio of services.
Direct peers
- Flourish Research: Flourish Research is an integrated clinical research site network built via acquisitions of regional sites, focused on multi-therapeutic outpatient trials. It is a direct comparable to Centricity's site-network model and patient recruitment approach.
- Benchmark Research: Benchmark Research is a clinical trial site network operating across multiple US states with multi-therapeutic capabilities, comparable to Centricity in scale, therapeutic breadth, and sponsor/CRO customer base.
- Velocity Clinical Research: Velocity is one of the largest integrated SMO/site networks in the US, acquired by GHO Capital in 2021 and continuing to consolidate regional research sites. It directly competes with Centricity for sponsor study placement across therapeutic areas.
- DM Clinical Research: DM Clinical Research operates a network of clinical trial sites in the southern US, conducting multi-specialty Phase I-IV trials for sponsors and CROs. It directly competes with Centricity for sponsor studies in overlapping regional markets.
- Meridien Research: Meridien Research is a multi-therapeutic clinical trial site network with locations across the southeastern US, matching Centricity's therapeutic breadth and patient-recruitment focus in overlapping geographies.
- Panther Clinical Research: Panther Clinical Research is a multi-site clinical research organization operating across the US with multi-therapeutic capabilities, directly comparable to Centricity's regional site network model and sponsor/CRO service offering.
Emerging players
- Elligo Health Research: Elligo is a technology-enabled SMO that brings clinical trials into physician practices and uses a patient identification platform. It competes with traditional site networks like Centricity by offering sponsors access to community-based patient populations without standing up dedicated sites.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
IACT Health social profiles
Digital presenceIACT Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
IACT Health leadership team
Management profileNumber of profiles
Profiles1 record
IACT Health subsidiaries and ownership
Company hierarchySubsidiaries1 record
IACT Health funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IACT Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IACT Health
What does IACT Health do?
IACT Health (operating as Centricity Research) operates one of the largest clinical research site networks in North America, with sites across the US and Canada. The company conducts clinical trials for pharmaceutical sponsors and Contract Research Organizations (CROs) across 35+ therapeutic areas including oncology, cardiology, pulmonology, and endocrinology, earning fees for patient enrollment, study execution, and data collection. Patients can also apply directly through the company's website to join paid clinical research studies, with additional free health screening services such as FibroScan, peanut allergy screening, and memory tests.
Is IACT Health a public or private company?
IACT Health is a private company. It is classified as unknown and is currently operating.
When was IACT Health founded?
IACT Health was founded in 2005. It employs 101 to 250 people.
Where is IACT Health based?
IACT Health is headquartered in Columbus, United States, in the North America region.
How does IACT Health make money?
One revenue line is on record: clinical Trial Site Services.
Who are IACT Health's main competitors?
Broad incumbents on record are Medpace, ICON plc and IQVIA. Direct peers are Flourish Research, Benchmark Research, Velocity Clinical Research, DM Clinical Research, Meridien Research and Panther Clinical Research. Elligo Health Research is listed as an emerging player.
Does IACT Health have an API?
No public API is recorded for IACT Health.
What industry is IACT Health in?
IACT Health's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs. Its NAICS code is 5417 and its SIC code is 8731.